ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer von Kyte, J. A., Andresen, N. K., Russnes, H. G., Fretland, S. O., Falk, R. S., Lingjaerde, O. C., Naume, B.

Volltext

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome von Bergamaschi, A, Tagliabue, E, Sørlie, T, Naume, B, Triulzi, T, Orlandi, R, Russnes, HG, Nesland, JM, Tammi, R, Auvinen, P, Kosma, V.M, Ménard, S, Børresen-Dale, A.L

Volltext

Nuclear CSPP1 expression defined subtypes of basal-like breast cancer von Sternemalm, J, Russnes, H G, Zhao, X, Risberg, B, Nord, S, Caldas, C, Børresen-Dale, A L, Stokke, T, Patzke, S

Volltext

Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers von Głodzik, D., Purdie, C., Rye, I.H., Simpson, P.T., Staaf, J., Span, P.N., Russnes, H.G., Nik-Zainal, S.

Volltext

ESMO Recommendations on clinical reporting of genomic test results for solid cancers von van de Haar, J., Roepman, P., Andre, F., Balmaña, J., Castro, E., Chakravarty, D., Curigliano, G., Czarnecka, A.M., Dienstmann, R., Horak, P., Italiano, A., Marchiò, C., Monkhorst, K., Pritchard, C.C., Reardon, B., Russnes, H.E.G., Sirohi, B., Sosinsky, A., Spanic, T., Turnbull, C., Van Allen, E., Westphalen, C.B., Tamborero, D., Mateo, J.

Volltext

Allele-specific copy number analysis of tumors von Van Loo, Peter, Nordgard, Silje H., Lingjærde, Ole Christian, Russnes, Hege G., Rye, Inga H., Sun, Wei, Weigman, Victor J., Marynen, Peter, Zetterberg, Anders, Naume, Bjørn, Perou, Charles M., Børresen-Dale, Anne-Lise, Kristensen, Vessela N.

Volltext

Incidence of breast cancer subtypes in immigrant and non-immigrant women in Norway von Hjerkind, Kirsti V, Johansson, Anna L V, Trewin, Cassia B, Russnes, Hege G, Ursin, Giske

Volltext

High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond von Edsjö, Anders, Russnes, Hege G., Lehtiö, Janne, Tamborero, David, Hovig, Eivind, Stenzinger, Albrecht, Rosenquist, Richard, Janowska, Agnieszka, Rioja, Alba López, Stenzinger, Albrecht, Razzak, Ali, Edsjö, Anders, Lepland, Anni, Marra, Antonio, Planken, Anu, Helland, Åslaug, Patocs, Attila, Mainoli, Beatrice, Ryll, Bettina, Brasiuniene, Birute, Kazdal, Daniel, Tamborero, David, Cerina, Dora, Hult, Ebba Hallersjö, Baltruškevičienė, Edita, Vrdoljak, Eduard, Hovig, Eivind, Chavarria, Elena, Garralda, Elena, Aas, Eline, Bjørgo, Elisa, Voest, Emile, Curigliano, Giuseppe, Fagereng, Gro Live, Gelderblom, Hans, Russnes, Hege G., Verheul, Henk, Timmer, Hans, Brana, Irene, Lugowska, Iwona, Lehtiö, Janne, Blay, Jean‐Yves, Oliveira, Julio, Rekker, Kadri, Toome, Kadri, Jalkanen, Katriina, Taskén, Kjetil, Smeland, Knut, Ojamaa, Kristiina, Rohrberg, Kristoffer Staal, Verlingue, Loic, Antouly, Manon, Mustonen, Mika, Zagami, Paola, Nagy, Péter, Nygren, Peter, Asplund, Peter, Sabaliauskaite, Rasa, Rosenquist, Richard, Henrique, Rui, Waalwijk van Doorn‐Khosrovani, Sahar Barjesteh, Brabrand, Sigmund, Ekman, Simon, Mohammad, Soemeya Haj, Jarmalaite, Sonata, Juslin, Tanja, Kahre, Tiina, Kringelbach, Tina, Guren, Tormod, Lassen, Ulrik, Grolmusz, Vince Kornél, Alberu, Xenia Villabour

Volltext

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients von Russnes, HG, Vollan, HKM, Lingjaerde, OC, Krasnitz, A, Lundin, P, Naume, B, Sorlie, T, Borgen, E, Rye, IH, Langerod, A, Chin, SF, Teschendorff, AE, Stephens, PJ, Maner, S, Schlichting, E, Baumbusch, LO, Karesen, R, Stratton, MP, Wigler, M, Caldas, C, Zetterberg, A, Hicks, J, Borresen-Dale, AL

Volltext

Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1) von Ohnstad, H.O., Blix, E.S., Akslen, L.A., Gilje, B., Raj, S.X., Skjerven, H., Borgen, E., Janssen, E.A.M., Mortensen, E., Brekke, M.B., Falk, R.S., Schlichting, E., Boge, B., Songe-Møller, S., Olsson, P., Heie, A., Mannsåker, B., Vestlid, M.A., Kursetgjerde, T., Gravdehaug, B., Suhrke, P., Sanchez, E., Bublevic, J., Røe, O.D., Geitvik, G.A., Halset, E.H., Rypdal, M.C., Langerød, A., Lømo, J., Garred, Ø., Porojnicu, A., Engebraaten, O., Geisler, J., Lyngra, M., Hansen, M.H., Søiland, H., Nakken, T., Asphaug, L., Kristensen, V., Sørlie, T., Nygård, J.F., Kiserud, C.E., Reinertsen, K.V., Russnes, H.G., Naume, B.

Volltext

Abstract P3-03-19: Tumor cell detection and immune profiling of lymph nodes from breast cancer patients by mass cytometry von Russnes, HG, Rye, IH, Huse, K, Schlichting, E, Garred, O, Mykelbust, JH

Volltext

Quantitative multigene FISH on breast carcinomas identifies der(1;16)(q10;p10) as an early event in luminal A tumors von Rye, Inga H., Lundin, Pär, Månér, Susanne, Fjelldal, Renathe, Naume, Bjørn, Wigler, Michael, Hicks, James, Børresen-Dale, Anne-Lise, Zetterberg, Anders, Russnes, Hege G.

Volltext

Abstract P3-05-04: Intra-tumor heterogeneity as a predictor of therapy response in HER2 positive breast cancer von Rye, IH, Helland, Å, Sætersdal, A, Naume, B, Almendro, V, Polyak, K, Børessen-Dale, A-L, Russnes, HG

Volltext

Number of risky lifestyle behaviors and breast cancer risk von Ellingjord-Dale, M, Vos, L, Hjerkind, KV, Hjartaker, A, Russnes, HG, Tretli, S, Hofvind, S, Dos-Santos-Silva, I, Ursin, G

Volltext

Breast cancer quantitative proteome and proteogenomic landscape von Johansson, HJ, Socciarelli, F, Vacanti, NM, Haugen, MH, Zhu, YF, Siavelis, I, Fernandez-Woodbridge, A, Aure, MR, Sennblad, B, Vesterlund, M, Branca, RM, Orre, LM, Huss, M, Fredlund, E, Beraki, E, Garred, O, Boeke, J, Sauer, T, Zhao, W, Nord, S, Hoglander, EK, Jans, DC, Brismar, H, Haukaas, TH, Bathen, TF, Schlichting, E, Naume, B, Luders, T, Borgen, E, Kristensen, VN, Russnes, HG, Lingjaerde, OC, Mills, GB, Sahlberg, KK, Borresen-Dale, AL, Lehtio, J

Volltext

ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer von Kyte, J. A, Andresen, N. K, Russnes, H. G, Fretland, S. Ø, Falk, R. S, Lingjærde, O. C, Naume, B

Volltext bestellen

Molecular subclassification of breast carcinomas based on aCGH, gene expression, IHC and ploidy – relevance for clinical outcome von Russnes, H.G, Sørlie, T, Krasnitz, A, Zetterberg, A, Naume, B, Borgen, E, Nesland, J.M, Wigler, M, Børresen-Dale, A.L, Hicks, J

Volltext

Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers von Głodzik, D, Purdie, C, Rye, IH, Simpson, PT, Staaf, J, Span, PN, Russnes, HG, Nik-Zainal, S

Volltext bestellen

Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity von Almendro, Vanessa, Cheng, Yu-Kang, Randles, Amanda, Itzkovitz, Shalev, Marusyk, Andriy, Ametller, Elisabet, Gonzalez-Farre, Xavier, Muñoz, Montse, Russnes, Hege G., Helland, Åslaug, Rye, Inga H., Borresen-Dale, Anne-Lise, Maruyama, Reo, van Oudenaarden, Alexander, Dowsett, Mitchell, Jones, Robin L., Reis-Filho, Jorge, Gascon, Pere, Gönen, Mithat, Michor, Franziska, Polyak, Kornelia

Volltext

Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors von Rye, Inga H., Trinh, Anne, Sætersdal, Anna B., Nebdal, Daniel, Lingjærde, Ole Christian, Almendro, Vanessa, Polyak, Kornelia, Børresen‐Dale, Anne‐Lise, Helland, Åslaug, Markowetz, Florian, Russnes, Hege G.

Volltext